Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Construction Press Releases.
Press releases published on May 2, 2025
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
WALTHAM, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
Beyond Oil Expands to Greece with New Distribution Agreement
GlobeNewswire
·
May 2, 2025
VANCOUVER, BC and KIBBUTZ YIFAT, Israel, May 02, 2025 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) (Frankfurt: UH9) ("Beyond Oil" or the "Company"), a food-tech innovation company dedicated to reducing health risks associated with fried …
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
SOUTH SAN FRANCISCO Calif. and SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that …
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
SAN FRANCISCO, May 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …
New Data at DDW 2025 Further Demonstrates the TissueCypher® Test's Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer
GlobeNewswire
·
May 2, 2025
Additionally, an expert physician panel convened by EndoscopyNow will host a product theater on Sunday, May 4, at 2:45 p.m. Pacific Time, titled, “The Time is Now: A Clinical Practice Model to Help Prevent Progression from Barrett's to EAC” FRIENDSWOOD, …
Zenith Labs TitanFlow Under Review: Prostate Support for Healthy Urinary Flow in Men Over Forty
GlobeNewswire
·
May 2, 2025
New York, May 02, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why urinary issues like frequent nighttime urination, urgency, and weak flow become more common in men over 40 The biological and hormonal causes behind prostate discomfort and …
Microchip Technology Appoints Long-Time TSMC Executive Rick Cassidy to Its Board of Directors
GlobeNewswire
·
May 2, 2025
CHANDLER, Ariz., May 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected and secure embedded control solutions, today announced that Rick Cassidy, Senior Vice President of Corporate …
COMSTOCK RESOURCES, INC. ANNOUNCES DUAL LISTING ON NYSE TEXAS
GlobeNewswire
·
May 2, 2025
FRISCO, TX, May 02, 2025 (GLOBE NEWSWIRE) -- Comstock Resources, Inc. ("Comstock" or the "Company") (NYSE: CRK) today announced a dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities exchange headquartered in Dallas, …
NXP Announces Availability of Proxy Materials for the Annual General Meeting of Shareholders to Be Held on June 11, 2025
GlobeNewswire
·
May 2, 2025
EINDHOVEN, The Netherlands, May 02, 2025 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI) will hold its annual meeting of shareholders on Wednesday, June 11, 2025 at 08.45 a.m. CET at the Sheraton Amsterdam Airport Hotel and Conference Center, …
Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications
GlobeNewswire
·
May 2, 2025
XI’AN, China, May 02, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, announced today that on April 29, …
XRP News: Buy $XDX Tokens Now Before XenDex Presale Ends Soon, as XRP Market Heats Up
GlobeNewswire
·
May 2, 2025
SYDNEY, May 02, 2025 (GLOBE NEWSWIRE) -- As excitement grips the XRP community following recent breakthroughs including ProShares’ XRP Futures ETF approval, Brazil’s XRP Spot ETF rollout, and the SEC’s lawsuit withdrawal, all eyes are now on XenDex, the …
Update on Market Making Arrangements
GlobeNewswire
·
May 2, 2025
Reykjavík, May 02, 2025 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company” or the “Corporation”) Update on Market Making Arrangements TORONTO, ONTARIO – May 02, 2025 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mining company with a …
Jushi Holdings Inc. Updates Call Time to 4:00 p.m. Eastern Time to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
May 2, 2025
BOCA RATON, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first …
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on May 1, 2025 the Company granted inducement awards to purchase up …
Taitron Announces Quarterly Cash Dividend
GlobeNewswire
·
May 2, 2025
LOS ANGELES, May 02, 2025 (GLOBE NEWSWIRE) -- Taitron Components Incorporated (NASDAQ:TAIT) today announced that its Board of Directors has declared a quarterly cash dividend of $0.05 per share of common stock, payable on May 30, 2025 to stockholders of …
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire
·
May 2, 2025
FOSTER CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, …
NurExone Expands European Engagement with Investor Events in Germany and Switzerland
GlobeNewswire
·
May 2, 2025
TORONTO and HAIFA, Israel, May 02, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system …
Beyond Osteo Under Review: Empower Health Labs Spartan Trick for Bone Health Support Against Osteoporosis
GlobeNewswire
·
May 2, 2025
New York, May 02, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: Why bone health quietly deteriorates with age and how it impacts long-term mobility The key signs and symptoms of osteoporosis that most people overlook How Empower Health Labs …
Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
GlobeNewswire
·
May 2, 2025
SAN CARLOS, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …